Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by 99942Apophis on Jul 26, 2021 2:50pm

Move to TSX

Should patients 16, 17 & 18 demonstrate a majority or even all show 100 percent CR then the assumption can be made that most of the remaining patients to be given the optimized treatment will also have that result.  We have heard in the past at some point Theralase will move from the Venture Exchange to the senior board TSX and also go after a Nasdaq listing, I would guess once 50 or 60 patients have proven this to be highly effective in the destruction of Cancer will we see that move or will that happen upon completion of Phase 2. Any thoughts?
Comment by skys1 on Jul 26, 2021 3:09pm
My thoughts -  I believe Roger originally said he would make a move to a more substantial stock exchange in June of 1996. In the interim I suspect Roger did some investigating and discovered that the costs of a move to a more respected exchange can be substantial as compared to the Ventures costs plus there are standards the have to be met that TLT hasn't come close to yet.I would also ...more  
Comment by skys1 on Jul 26, 2021 3:11pm
Please excuse me! That should have been June of 2016, not 1996. I guess I'm showing my age.
Comment by livermore2 on Jul 26, 2021 3:15pm
I think this would happen if we approach a 1billion MC which can happen very quickly in the biotechnology industry. My fear is being taken out by a rival pharma company beforehand though.
Comment by skys1 on Jul 26, 2021 3:28pm
True livedrmore, a move on TLT by a member of the Big Pharma community could occur but I don't see it happening until their CR % gets in the 60s range. What I think could occur in advance of that though is an agreement with The Canadian government or someone else in regards the potential of a virus vaccine application of 1433. No one is going tp pour a lot of money into vaccine research and ...more  
Comment by livermore2 on Jul 26, 2021 3:40pm
Yes, I agree with your thinking. Just look at Moderna's stock price over the last year and a half- know it's a special case but always good to dream!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250